View Older Stories
-
Notable Mergers and Acquisitions of the Day 09/29: (HGIC) (NUVA) (MRK)/(JNJ)
-
After-Hours Movers 09/28: (TWI) (THO) (ATO) (HPQ) Higher; (BDSI) (AMD) (WOR) (MOS) Lower
-
Jefferies Upgrades Merck (MRK) to Buy
-
Q2 Preview: Divide and Conquer May Not Be Pfizer's (PFE) Best Option; Pipeline Looks Strong
-
Trading Radar for 07/28: Chevron (CVX), Merck & Co. (MRK), Weyerhaeuser (WY), Newell Rubbermaid (NWL) Report
-
Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
-
Notable 52-Week Highs and Lows of the Day 05/12: (SYMC) (QCOR) (TJX) High; (CLWR) (PNSN) (HEV) Low
-
Top 10 News Items 4/25-4/29: Bernanke Conducts First-Ever FOMC Press Briefing, Signals QE3 May Not Happen; Gold, Silver Continue to Charge Higher; Q1 US GDP Worse-Than-Expected
-
Hapoalim Upgrades Merck (MRK) to Buy Following Q1 Report
-
Trading Radar for 04/29: Chevron (CVX), Caterpillar (CAT), Lear (LEA), Weyerhaeuser (WY), WABCO (WAB) Report
-
Highlights From JNJ's Q1 Conference Call: U.S. Sales Declined by 0.6%; Total Worldwide Revenues Increased 3.5%
-
Canaccord Genuity Morning Coffee on Merck & Co. (MRK) and Sanofi-Aventis (SNY): So Long, Farewell, Au Revoir
-
Top 10 News Items 1/31-2/4: Jobs Report Adversely Impacted by Severe Winter Weather, Stocks Shrug at Unrest in Egypt, Q4 Earnings Season Winding Down
-
Merck (MRK) Falling on Weak Guidance; Analysts Weigh In
-
Merck (MRK) Posts Strong Q4; Shares Dip on FY11 EPS Forecast
-
Trading Radar for 02/03: Las Vegas Sands (LVS), CIGNA (CI), Kellogg (K), ON Semi (ONNN), Int'l Paper (IP) Report
-
Barclays on U.S. Major Pharmaceuticals: U.S. Major Pharma 2011 Outlook: A View Beyond the Cliff
-
Unusual 11 Mid-Day Movers 12/23: ELC, RPRX, RPC, JAS, ACAD, XOMA Higher; AIB, ARWR, BASI, EMKR, ONTY Lower
-
Q3 Preview: Pfizer (PFE) Chugging Strong Into Earnings; M&A and Pipeline Key Focal Points (MRK, NVS)
-
Merck (MRK ) Income Tumbles 90% on Acquisition Charges, Federal Investigation
-
Trading Radar for 10/29: Chevron (CVX), Merck & Co. (MRK), Rockwell Collins (COL), Weyerhaeuser (WY) Report
-
Q3 Preview: Merck (MRK) Trading Strong Into Earnings, Looks to Nearly Double-Up Revs Y/Y (PFE, GSK, SNY)
